Day: April 8, 2020

MONTRÉAL, April 08, 2020 (GLOBE NEWSWIRE) — Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELXIF) (FRA 2QLA) (“ELIXXER” or (the “Company”) is pleased to announce that its pharmaceutical partner, Freia launches production of ImmunoV Forte, to improve and protect respiratory function in the human body against airborne infections.   Freia is initiating clinical trials on the active ingredients in ImmunoV Forte that aid and protect the human respiratory tract from external environmental attacks such as respiratory viruses, bacteria, smoke and pollution.  In being compliant with Canadian Exchange regualators, both Elixxer and Freia are not making any expressed or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.  Post trials the company will update the market as to...

TORONTO, April 08, 2020 (GLOBE NEWSWIRE) — Teranga Gold Corporation (“Teranga” or the “Company”) (TSX:TGZ; OTCQX:TGCDF) today announced the appointment of Simon Bottoms, MGeol, FGS CGeol, FAusIMM, to the Company’s board of directors, effective immediately. Mr. Bottoms was nominated to join Teranga’s board of directors by Barrick Gold Corporation (“Barrick”), the Company’s second largest shareholder.  Pursuant to the terms of an investor agreement related to the Company’s recent acquisition of the Massawa gold project, Barrick is entitled to nominate one board member so long as it retains at least a 10% ownership interest in Teranga.Mr. Bottoms is currently Senior Vice President Africa & Middle East Mineral Resource Manager for Barrick, where he is responsible for the management of all Africa and Middle East mine operations...

Safety of personnel, patients and healthcare providers remains our top priority Drug supply remains well-stocked with patients having access to uninterrupted supply of Firdapse® (amifampridine) 10mg Catalyst partners with First Responders Children’s Foundation to support COVID-19 EMERGENCY RESPONSE FUNDCORAL GABLES, Fla., April 08, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today provided an update on certain impacts of COVID-19 on its business operations.“We are committed to protecting the safety and well-being of our personnel, the entire LEMS community, healthcare providers, patients in clinical trials,...

HONOLULU, April 08, 2020 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE American: BRN) (the “Company”) today announced that the NYSE American LLC (the “Exchange”) has accepted the Company’s plan of compliance (the “Plan”) for continued listing on the Exchange.As previously reported, on January 13, 2020, the Company received a letter from NYSE American Staff indicating that the Company is not in compliance with certain continued listing standards relating to stockholders equity as set forth in Part 10, Section 1003 of the NYSE American Company Guide (the “Guide”). Based on the Company’s annual report on Form 10-K for the fiscal year ended September 30, 2019, which was filed with the Securities and Exchange Commission (SEC) on December 20, 2019, the Company was below compliance with Part 10, Sections 1003(a)(i) and (a)(ii) of...

NVX-CoV2373 identified as SARS-CoV-2 candidate for Phase 1 clinical trialIn preclinical studies, NVX-CoV2373 demonstrated high immunogenicity and stimulated high levels of neutralizing antibodiesFirst-in-human Phase 1 clinical trial accelerated to mid-May with preliminary results in JulyGMP clinical production initiated at Emergent BioSolutions with ability to leverage capacity for large scale manufacturingGAITHERSBURG, Md., April 08, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using Novavax’ proprietary nanoparticle technology, and will initiate a first-in-human trial in mid-May. Novavax’ proprietary Matrix-M™...

Zai Lab obtains rights to develop and exclusively commercialize REGN1979 in oncology in mainland China, Hong Kong, Taiwan and MacauCollaboration will also support enrollment of regional patients into Regeneron’s global trials evaluating REGN1979 in B-cell non-Hodgkin lymphoma (B-NHL)Zai Lab to host conference call and webcast today at 8:00 a.m. ESTTARRYTOWN, N.Y. and SHANGHAI, China, April 08, 2020 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Zai Lab Limited (NASDAQ: ZLAB) today announced a strategic collaboration for the development and commercialization of REGN1979 (CD20xCD3 bispecific antibody) in mainland China, Hong Kong, Taiwan and Macau. The collaboration will support global clinical development for REGN1979, starting with the ongoing potentially registrational Phase 2 program in B-cell non-Hodgkin...

ST. JOHN’S, Newfoundland, April 08, 2020 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG) (OTCQB: KRKNF) (“Kraken” or the “Company”), is pleased to announce that it has entered into a Partnership Agreement with Greensea Systems, Inc., creator of OPENSEA, an open architecture robotic platform. This partnership will expand upon the collaborative efforts already undertaken between the two companies to rapidly advance the capabilities of marine robotics. Under the agreement, Greensea will support development, integration, and testing work with Kraken across several of Kraken’s technology platforms. The companies have worked together over the last twelve months to utilize the OPENSEA Platform and provide a robust, modular, and extensible software architecture for Kraken’s autonomous underwater vehicles and towed systems.This Partnership...

IONE, CA, April 08, 2020 (GLOBE NEWSWIRE) — Purebase Corporation (OTCQB: PUBC), a diversified resource company, headquartered in Ione, California, today announced the appointment of Jeffrey Guzy to the company’s Board of Directors as an Independent Board Director, effective April 8th, 2020. Mr. Guzy will also chair the newly created Audit and Compensation Committees. Mr. Calvin Lim, who has served as an Independent Board Member of Purebase since January 2015 will be stepping down effective April 8th, 2020.Purebase’s Chairman and CEO, Scott Dockter stated, “We are very pleased to have Jeff join the Board of Directors of Purebase. He has a wealth of knowledge and experience in public company corporate governance that will serve us well as we continue to grow the Company and start preparing our application process to uplist to...

Los Angeles , CA, April 08, 2020 (GLOBE NEWSWIRE) — Los Angeles, California /GLOBENEWSWIRE/- April 8, 2020 -KRONOS ADVANCED TECHNOLOGIES, Inc., (OTC:KNOS) (“KNOS” or the “Company”) a proprietary product development and production company that has significantly changed the way air is moved, filtered and sterilized announced today it has secured exclusive North and South American production and distribution rights for an air purification and disease destruction product line that utilizes the Kronos(R)  CORE technology that has been developed by Kronos to produce, market and distribute commercial and residential air purification products, bacteriological and virus destruction devices. The agreement provides Kronos with the exclusive license to manufacture, use and sell these products in the Americas. The first...

DASSAULT SYSTEMES TO PUBLISHITS FIRST QUARTER 2020 RESULTS,WEBCAST AND CONFERENCE CALL ON APRIL 23rd, 2020  VÉLIZY-VILLACOUBLAY, France — April 8th, 2020 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, will publish its operating performance for the first quarter 2020 ended March 31st, 2020 on Thursday, April 23rd, 2020.The management of Dassault Systèmes will host a webcast at 10.00 am Paris time – 09.00 am London time, and will then also host a conference call at 9:00am New York time – 3:00pm Paris time – 2:00pm London time.Both the webcast and the conference call will be available live and as replay on Dassault Systèmes’ investor website at https://investor.3ds.com.Please follow the directions...